CalciMedica, a clinical-stage biopharmaceutical company, announced its management will participate in a fireside chat at the Guggenheim 3rd Annual Healthcare Innovation Conference on November 10, 2026. The company is developing novel therapies targeting calcium release-activated calcium (CRAC) channels for inflammatory and cardiopulmonary diseases. Their pipeline includes two CRAC inhibitors, Auxora™ for intravenous use and CM5480 for oral dosing, both aimed at treating pulmonary hypertension and acute pancreatitis. Investors can watch a live webcast of the presentation, with a replay available for 90 days on CalciMedica's website.
CalciMedica's upcoming participation in the Guggenheim Healthcare Innovation Conference provides context for healthcare sector activity. For readers following the health sector, here is Pluang's market snapshot as of Nov 03, 2026 20:11 WIB: Among 150 priced US health stocks, 75 rose and 69 fell. Notable movers include AHCO at USD 6.49 with a 1-day change of +9.81% and a typical hold time of 21 days, RVTY at USD 165.00 with +8.80% change and a 13-day hold, and NBIX at USD 155.03 with +6.66% change and a 28-day hold, though NBIX saw 100% sell order activity on Pluang.
The global Automatic FOUP Opener Market is projected to grow from USD 4.41 billion in 2026 to USD 6.04 billion by 2032, expanding at a CAGR of 5.36%. Growth is driven by increasing fab automation, stricter contamination control requirements, and dema...
Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...
Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...
Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...
Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...
